76 related articles for article (PubMed ID: 10212826)
1. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications.
Southgate J; Harnden P; Trejdosiewicz LK
Histol Histopathol; 1999 Apr; 14(2):657-64. PubMed ID: 10212826
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of cytokeratins as tumor markers.
Barak V; Goike H; Panaretakis KW; Einarsson R
Clin Biochem; 2004 Jul; 37(7):529-40. PubMed ID: 15234234
[TBL] [Abstract][Full Text] [Related]
3. Normal human urothelial cells in vitro: proliferation and induction of stratification.
Southgate J; Hutton KA; Thomas DF; Trejdosiewicz LK
Lab Invest; 1994 Oct; 71(4):583-94. PubMed ID: 7967513
[TBL] [Abstract][Full Text] [Related]
4. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens.
McKenney JK; Desai S; Cohen C; Amin MB
Am J Surg Pathol; 2001 Aug; 25(8):1074-8. PubMed ID: 11474293
[TBL] [Abstract][Full Text] [Related]
5. Oral cytokeratins in health and disease.
Rao RS; Patil S; Ganavi BS
J Contemp Dent Pract; 2014 Jan; 15(1):127-36. PubMed ID: 24939280
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
7. Uroplakins in urothelial biology, function, and disease.
Wu XR; Kong XP; Pellicer A; Kreibich G; Sun TT
Kidney Int; 2009 Jun; 75(11):1153-1165. PubMed ID: 19340092
[TBL] [Abstract][Full Text] [Related]
8. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis.
Laguna P; Smedts F; Nordling J; Horn T; Bouchelouche K; Hopman A; de la Rosette J
Am J Clin Pathol; 2006 Jan; 125(1):105-10. PubMed ID: 16482998
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
[TBL] [Abstract][Full Text] [Related]
10. The difference between cytokeratin 20 expression in high- and low-grade urothelial bladder carcinomas: A cross-sectional study.
Warli SM; Kadar DD; Siregar GP; Husein A
Urol Ann; 2023; 15(4):383-387. PubMed ID: 38074175
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer.
Dyrskjøt L; Hansel DE; Efstathiou JA; Knowles MA; Galsky MD; Teoh J; Theodorescu D
Nat Rev Dis Primers; 2023 Oct; 9(1):58. PubMed ID: 37884563
[TBL] [Abstract][Full Text] [Related]
12. Urine biomarkers in bladder cancer - current status and future perspectives.
Maas M; Todenhöfer T; Black PC
Nat Rev Urol; 2023 Oct; 20(10):597-614. PubMed ID: 37225864
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes.
Abdel-Hamid AAM; Firgany AEL
J Microsc Ultrastruct; 2023; 11(1):34-40. PubMed ID: 37144164
[TBL] [Abstract][Full Text] [Related]
14. An immunoresponsive three-dimensional urine-tolerant human urothelial model to study urinary tract infection.
Jafari NV; Rohn JL
Front Cell Infect Microbiol; 2023; 13():1128132. PubMed ID: 37051302
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children.
Planta D; Gerwinn T; Salemi S; Horst M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835106
[TBL] [Abstract][Full Text] [Related]
16. The Development of Non-Invasive Diagnostic Tools in Bladder Cancer.
Schulz A; Loloi J; Pina Martina L; Sankin A
Onco Targets Ther; 2022; 15():497-507. PubMed ID: 35529887
[TBL] [Abstract][Full Text] [Related]
17. Barrier-Forming Potential of Epithelial Cells from the Exstrophic Bladder.
Hinley J; Duke R; Jinks J; Stahlschmidt J; Keene D; Cervellione RM; Mushtaq I; De Coppi P; Garriboli M; Southgate J
Am J Pathol; 2022 Jun; 192(6):943-955. PubMed ID: 35358476
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
Völkel C; De Wispelaere N; Weidemann S; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Krech RH; Dum D; Krech T; Marx AH; Simon R; Burandt E; Menz A
Virchows Arch; 2022 Feb; 480(2):433-447. PubMed ID: 34559291
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry as a paramount tool in research of normal urothelium, bladder cancer and bladder pain syndrome.
Zupančič D; Romih R
Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33764020
[TBL] [Abstract][Full Text] [Related]
20. Can new immunoassay techniques improve bladder cancer diagnostics With protein biomarkers?
Shlyapnikov YM; Malakhova EA; Vinarov AZ; Zamyatnin AA; Shlyapnikova EA
Front Mol Biosci; 2020; 7():620687. PubMed ID: 33659273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
